Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Friday 1 November 2024, 01:00 AM
14 minutes to Read
Douglas Pharmaceutical’s work in finding new uses for old drugs, plus developing generic drugs, will be boosted by a $35 million research and development facility. Fiona Cassie finds out more about the growing Douglas empire